RecruitingNot Applicable

Familia Imara: A Parenting Program to Reduce Family Violence in Tanzania

Tanzania6,216 participantsStarted 2026-05-02

Plain-language summary

This cluster-randomized controlled trial will evaluate the effectiveness, implementation, and scalability of Familia Imara, a group-based, couples-focused, community health worker (CHW)-delivered parenting program, on reducing intimate partner violence (IPV), harsh discipline, and improving child development and nutrition outcomes in the Mara and Geita regions of Tanzania. Villages will be randomly assigned to either an intervention or control arm. The study will be implemented in two sequential cohorts. In Cohort 1, a traditional randomized controlled trial will compare intervention villages receiving the program to control villages receiving no intervention (waitlist control), with delivery supported primarily by implementing partners in collaboration with government supervisors. In Cohort 2, the same villages will retain their original assignment. Intervention villages will receive the program under a government-led delivery model to assess scalability and integration into existing systems, while control villages will transition from waitlist to receive the intervention. Evidence generated will inform policy and practice for preventing family violence and promoting early childhood development at scale.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The household has a child aged 0-24 months at enrollment * The child has a primary female caregiver (i.e., mother) and a primary male caregiver (i.e., father) who are in a partnered relationship * Primary female caregiver, primary male caregiver, and child reside together in the same household * Both caregivers provide written informed consent for themselves and their child to participate in the study Exclusion Criteria: * Need to satisfy the inclusion criteria * Expecting to relocate in the next year

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Maternal intimate partner violence victimization

Timeframe: Baseline, 11 months, 22 months

Child dietary diversity

Timeframe: Baseline, 11 months, 22 months

Parental harsh disciplinary practices

Timeframe: Baseline, 11 months, 22 months

Caregiver Reported Early Development Instrument (CREDI) long form

Timeframe: Baseline, 11 months, 22 months

Trial details

NCT IDNCT07574567

SponsorSaini Das

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-01

Contact for this trial

Joshua Jeong, ScD

404-727-2671 joshua.jeong@emory.edu

View on ClinicalTrials.gov More Intimate Partner Violence (IPV) trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Maternal intimate partner violence victimization

Timeframe: Baseline, 11 months, 22 months

Child dietary diversity

Timeframe: Baseline, 11 months, 22 months

Parental harsh disciplinary practices

Timeframe: Baseline, 11 months, 22 months

Caregiver Reported Early Development Instrument (CREDI) long form

Timeframe: Baseline, 11 months, 22 months